Artal Group S.A. Tg Therapeutics, Inc. Transaction History

Artal Group S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$10.23 - $19.34 $5.23 Million - $9.89 Million	511,389 New	511,389 $7.69 Million
Q2 2022 Aug 11, 2022	SELL	$3.74 - $10.66 $2.99 Million - $8.53 Million	-800,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $22.8 Million - $34.3 Million	-700,000 Reduced 46.67%	800,000 $31 Million
Q3 2020 Nov 13, 2020	SELL	$18.49 - $27.24 $4.62 Million - $6.81 Million	-250,000 Reduced 14.29%	1,500,000 $40.1 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $6.68 Million - $16.4 Million	750,000 Added 75.0%	1,750,000 $34.1 Million
Q1 2020 May 14, 2020	BUY	$7.14 - $15.99 $2.5 Million - $5.6 Million	350,000 Added 53.85%	1,000,000 $9.84 Million
Q4 2019 Feb 13, 2020	SELL	$5.1 - $11.2 $1.28 Million - $2.8 Million	-250,000 Reduced 27.78%	650,000 $7.22 Million
Q2 2019 Aug 09, 2019	BUY	$6.27 - $8.65 $627,000 - $865,000	100,000 Added 12.5%	900,000 $7.79 Million
Q1 2019 May 10, 2019	BUY	$4.02 - $8.04 $1.61 Million - $3.22 Million	400,000 Added 100.0%	800,000 $6.43 Million
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $1.88 Million - $2.25 Million	150,000 Added 60.0%	400,000 $5.26 Million
Q1 2018 May 10, 2018	SELL	$8.7 - $16.8 $1.31 Million - $2.52 Million	-150,000 Reduced 37.5%	250,000 $3.55 Million
Q3 2017 Nov 08, 2017	BUY	$10.0 - $12.7 $4 Million - $5.08 Million	400,000	400,000 $4.74 Million

345

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.86B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.